Activities of DL-α-Difluoromethylarginine and Polyamine Analogues against Cryptosporidium parvum Infection in a T-Cell Receptor Alpha-Deficient Mouse Model

The in vivo effectiveness of a series of conformationally restricted polyamine analogues alone and selected members in combination with DL-α-difluoromethylarginine against Cryptosporidium parvum infection in a T-cell receptor alpha-deficient mouse model was tested. Polyamine analogues were selected...

Full description

Saved in:
Bibliographic Details
Published in:Antimicrobial Agents and Chemotherapy Vol. 51; no. 4; pp. 1234 - 1239
Main Authors: Yarlett, N, Harp, J.A, Wannemuehler, M.J, Morada, M, Bellcastro, J, Upton, S.J, Marton, L.J, Frydman, B.J
Format: Journal Article
Language:English
Published: United States American Society for Microbiology 01-04-2007
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The in vivo effectiveness of a series of conformationally restricted polyamine analogues alone and selected members in combination with DL-α-difluoromethylarginine against Cryptosporidium parvum infection in a T-cell receptor alpha-deficient mouse model was tested. Polyamine analogues were selected from the extended bis(ethyl)-sym-homospermidine or bis(ethyl)-spermine backbone having cis or trans double bonds at the center of the molecule. The cis isomers were found to have significantly greater efficacy in both preventing and curing infection in a mouse model than the trans polyamine analogues when tested in a T-cell receptor alpha-deficient mouse model. When tested in combination with DL-α-difluoromethylarginine, the cis-restricted analogues were found to be more effective in preventing oocyst shedding. This study demonstrates the potential of polyamine analogues as anticryptosporidial agents and highlights the presence of multiple points in polyamine synthesis by this parasite that are susceptible to inhibition resulting in growth inhibition.
Bibliography:http://hdl.handle.net/10113/13634
http://dx.doi.org/10.1128/AAC.01040-06
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Corresponding author. Mailing address: Haskins Laboratories, Pace University, 41 Park Row, New York, NY 10038. Phone: (212) 346-1853. Fax: (212) 346-1586. E-mail: nyarlett@pace.edu
ISSN:1098-6596
0066-4804
1098-6596
DOI:10.1128/AAC.01040-06